Jul
21
ScienceDaily July 21, 2008 — The CUPID Cannabinoid Use in Progressive Inflammatory brain Disease study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis MS has been recruited to the study.
CUPID is a clinical trial which will evaluate whether tetrahydrocannabinol THC, one of many compounds found in the in the cannabis plant and the main active ingredient is able to slow the progression of MS.
This is an important study for people with MS because current treatments either target the immune system in the early stages of MS, or are aimed at easing specific symptoms such as muscle spasms or bladder problems. At present there is no treatment which slows progression of the disease.
read the rest: Can Cannabis Compounds Slow The Progression Of Multiple Sclerosis?
Comments
Leave a Reply